blue cross blue shield ppo glp 1 coverage Does (BCBS) Cover Wegovy? Why we are changing coverage

GLP-1 receptors in the hypothalamus region control appetite, satiety, food reward

Despite the promising potential of GLP-1 RAs, it is essential to conduct further clinical studies to confirm their long-term efficacy and safety in patients with HFpEF

For tirzepatide (Zepbound) Jastreboff and colleagues reported in the New England Journal of Medicine in 2022 that at maximal doses, the percent of individuals reporting side effects were as follows: Nausea 31.0% Diarrhea 23.0% Vomiting 12.2% Constipation 11.7% Bettge and colleagues conducted a study published in Diabetes, Obesity, and Metabolism in 2017 that showed that individuals who were taking metformin while taking a GLP-1 were more likely to have side effects, especially nausea and vomiting

FOR GLP-1 THE SAME AS OZEMPIC SOURCE: MedlinePlus